• combined therapy amylin + leptin agonism results in more weight loss in subjects with obesity than either treatment alone and may have therapeutic utility as part of an integrated neurohormonal approach to obesity pharmacotherapy. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.